Evidence map›Paper›PMID 15965500›Full record

ArticleThe Journal of clinical investigation2005

The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A.

Raj Kishore, Gangjian Qin, Corinne Luedemann, Evelyn Bord, Allison Hanley, Marcy Silver, Mary Gavin, Young-sup Yoon, David Goukassian, David Goukassain and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Bidirectional Tumor-Promoting Activities of Macrophage Ezrin.International journal of molecular sciences · 2020
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Scaffolding during the cell cycle by A-kinase anchoring proteins.Pflugers Archiv : European journal of physiology · 2015
    Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
    Goukassain, David [corrected to Goukassian, David]
  • Erratum issued
    Yoon, Young-sup [added]
5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Raj KishoreDivision of Cardiovascular Research, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA. raj.kishore@tufts.edu
Gangjian Qin
Corinne Luedemann
Evelyn Bord
Allison Hanley
Marcy Silver
Mary Gavin
Young-sup Yoon
David Goukassian
David Goukassain
Douglas W Losordo
Tufts University · US

Funding

VEGF transfer to promote angiogenesis in advanced CHFP01HL066957 · NHLBI · CARITAS ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 2001 to 2005
$8.7M
Therapeutic Angiogenesis in Vascular Medicine IVR01HL053354 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KISHORE, RAJ · 1995 to 2015
$4.2M
RE-ENDOTHELIALIZATION AND RESTENOSIS IIR01HL057516 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 1997 to 2008
$3.3M
RESTENOSIS AND ENDOTHELIAL PROLIFERATIONR01HL063414 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 1999 to 2007
$2.5M
ESTROGEN, ANGIOGENESIS AND ENDOTHELIAL PROGENITOR CELLSR01HL063695 · NHLBI · CARITAS ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 2001 to 2004
$1.7M
THERAPEUTIC ANGIOGENESIS IN VASCULAR MEDICINE IIR37HL053354 · NHLBI · CARITAS ST. ELIZABETH'S MEDICAL CENTER · PI ISNER, JEFFREY · 2000 to 2001
$726k
NHLBI NIH HHS HL53354NHLBI NIH HHS HL57516NHLBI NIH HHS HL63695NHLBI NIH HHS HL66957NHLBI NIH HHS P01 HL066957NHLBI NIH HHS R01 HL053354NHLBI NIH HHS R01 HL057516NHLBI NIH HHS R01 HL063414NHLBI NIH HHS R01 HL063695NHLBI NIH HHS R01 HL63414NHLBI NIH HHS R37 HL053354
6 · The paper itself

Abstract

TNF-alpha modulates EC proliferation and thereby plays a central role in new blood vessel formation in physiologic and pathologic circumstances. TNF-alpha is known to downregulate cyclin A, a key cell cycle regulatory protein, but little else is known about how TNF-alpha modulates EC cell cycle and angiogenesis. Using primary ECs, we show that ezrin, previously considered to act primarily as a cytoskeletal protein and in cytoplasmic signaling, is a TNF-alpha-induced transcriptional repressor. TNF-alpha exposure leads to Rho kinase-mediated phosphorylation of ezrin, which translocates to the nucleus and binds to cell cycle homology region repressor elements within the cyclin A promoter. Overexpression of dominant-negative ezrin blocks TNF-alpha-induced modulation of ezrin function and rescues cyclin A expression and EC proliferation. In vivo, blockade of ezrin leads to enhanced transplanted EC proliferation and angiogenesis in a mouse hind limb ischemia model. These observations suggest that TNF-alpha regulates angiogenesis via Rho kinase induction of a transcriptional repressor function of the cytoskeletal protein ezrin and that ezrin may represent a suitable therapeutic target for processes dependent on EC proliferation.

Indexed as

AnimalsCattleCell ProliferationCyclin ACytoskeletal ProteinsEndothelial CellsExtremitiesEzrinGene ExpressionHumansIschemiaMiceMice, NudeNeovascularization, PhysiologicPhosphoproteinsTranscription, GeneticCyclin ACytoskeletal ProteinsEzrinPhosphoproteinsTumor Necrosis Factor-alpha

Identifiers

PMID15965500
PMCPMC1150283
OpenAlexW2157503416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.